Literature DB >> 19797753

Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study.

Jennifer C Nelson1, Rachel C L Bittner, Lora Bounds, Shanshan Zhao, James Baggs, James G Donahue, Simon J Hambidge, Steven J Jacobsen, Nicola P Klein, Allison L Naleway, Kenneth M Zangwill, Lisa A Jackson.   

Abstract

OBJECTIVES: We studied compliance with multiple-dose vaccine schedules, assessed factors associated with noncompliance, and examined timeliness of series completion among older children, adolescents, and adults.
METHODS: We conducted a large, multisite, retrospective cohort study of older children, adolescents, and adults in the Vaccine Safety Datalink population from 1996 through 2004. We quantified the rates of completion of all required doses for varicella, hepatitis A, and hepatitis B vaccines according to their recommended schedules.
RESULTS: Among those who received a first dose of varicella (n = 16 075), hepatitis A (n = 594 917), and hepatitis B (n = 590 445) vaccine, relatively few completed the series (55%-65% for hepatitis B vaccine and 40%-50% for hepatitis A and varicella vaccines in most age groups). Compliance was lowest among adolescents (35.9%) and Medicaid recipients (29.7%) who received varicella vaccine and among younger adult age groups who received hepatitis A vaccine (25%-35% across those age groups). Even among series completers, there was a relatively long interval of undervaccination between the first and last doses.
CONCLUSIONS: Compliance with multiple-dose vaccine series among older children, adolescents, and adults is suboptimal. Further evaluations of strategies to improve compliance in these populations are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797753      PMCID: PMC4504385          DOI: 10.2105/AJPH.2008.151332

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  33 in total

1.  Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.

Authors:  Y Ashur; R Adler; M Rowe; D Shouval
Journal:  Vaccine       Date:  1999-05-04       Impact factor: 3.641

2.  Health outcomes among Hispanic subgroups: data from the National Health Interview Survey, 1992-95.

Authors:  A Hajat; J B Lucas; R Kington
Journal:  Adv Data       Date:  2000-02-25

3.  Overview of clinical studies with hepatitis B vaccine made by recombinant DNA.

Authors:  B A Zajac; D J West; W J McAleer; E M Scolnick
Journal:  J Infect       Date:  1986-07       Impact factor: 6.072

4.  Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.

Authors:  T Coates; R Wilson; G Patrick; F André; V Watson
Journal:  Clin Ther       Date:  2001-03       Impact factor: 3.393

5.  Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers.

Authors:  Y C Horng; M H Chang; C Y Lee; A Safary; F E Andre; D S Chen
Journal:  J Gastroenterol Hepatol       Date:  1993 Jul-Aug       Impact factor: 4.029

6.  Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group.

Authors:  B J Kuter; A Ngai; C M Patterson; B O Staehle; I Cho; H Matthews; P J Provost; C J White
Journal:  Vaccine       Date:  1995-08       Impact factor: 3.641

7.  Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-12-27

8.  National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines.

Authors:  Cynthia M Rand; Laura P Shone; Christina Albertin; Peggy Auinger; Jonathan D Klein; Peter G Szilagyi
Journal:  Arch Pediatr Adolesc Med       Date:  2007-03

9.  Hepatitis A 2004 vaccination in children: methods and findings of a survey in two states.

Authors:  Anthony Fiore; Lisa Carley Baxter; Beth P Bell; Ron Hershow; Doug Passaro; Susan Twiddy; Rodney Baxter; Paul S Levy
Journal:  Am J Prev Med       Date:  2007-10       Impact factor: 5.043

10.  A managed care organization's attempt to increase influenza and pneumococcal immunizations for older adults in an acute care setting.

Authors:  H G Bloom; D A Wheeler; J Linn
Journal:  J Am Geriatr Soc       Date:  1999-01       Impact factor: 5.562

View more
  34 in total

1.  Shortened Intervals during Heterologous Boosting Preserve Memory CD8 T Cell Function but Compromise Longevity.

Authors:  Emily A Thompson; Lalit K Beura; Christine E Nelson; Kristin G Anderson; Vaiva Vezys
Journal:  J Immunol       Date:  2016-02-22       Impact factor: 5.422

2.  Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus.

Authors:  Eduardo Lujan; Kathleen Winter; Jillandra Rovaris; Qin Liu; Dan M Granoff
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

3.  Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants.

Authors:  Kimberly J Hassett; David J Vance; Nishant K Jain; Neha Sahni; Lilia A Rabia; Megan C Cousins; Sangeeta Joshi; David B Volkin; C Russell Middaugh; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2015-01-11       Impact factor: 3.534

4.  Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis.

Authors:  Phuc Le; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2016-10-14       Impact factor: 5.128

5.  Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults.

Authors:  Phuc Le; Michael B Rothberg
Journal:  JAMA Intern Med       Date:  2018-02-01       Impact factor: 21.873

6.  Perceived Barriers and Trends in HPV Vaccination via Patient Survey Responses at Kalamazoo, Michigan's Federally-Qualified Health Center.

Authors:  Nathan VanderVeen; Arika Wieneke; Samantha Tran; Amie Kim; Kathryn Davis; Debra Taubel
Journal:  J Community Health       Date:  2020-02

7.  Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses.

Authors:  Lea E Widdice; David I Bernstein; Anthony C Leonard; Keith A Marsolo; Jessica A Kahn
Journal:  Pediatrics       Date:  2010-12-13       Impact factor: 7.124

Review 8.  Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence.

Authors:  Ingrid T Katz; Norma C Ware; Glenda Gray; Jessica E Haberer; Claude A Mellins; David R Bangsberg
Journal:  Sex Health       Date:  2010-09       Impact factor: 2.706

9.  Addressing adolescent immunization disparities: a retrospective analysis of school-based health center immunization delivery.

Authors:  Steven G Federico; Lisa Abrams; Rachel M Everhart; Paul Melinkovich; Simon J Hambidge
Journal:  Am J Public Health       Date:  2010-07-15       Impact factor: 9.308

10.  Challenges with hepatitis B vaccination of high risk adults - A pilot program.

Authors:  Carolyn B Bridges; Tureka L Watson; Noele P Nelson; Maribel Chavez-Torres; Patrick Fineis; Boatemaa Ntiri-Reid; Edward Wake; Judith M Leahy; Anita K Kurian; Mary Ann K Hall; Erin D Kennedy
Journal:  Vaccine       Date:  2019-07-11       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.